Burkina Faso began vaccinating 9-year-old girls against HPV in 2022 with Gavi support. A model found vaccination could prevent 37% to 72% of cervical cancer cases and deaths and is cost-effective.
A static cohort model of the impact and cost-effectiveness of HPV vaccination of 9-year-old girls in Burkina Faso over 2022 to 2031, comparing four vaccines with no vaccination, using local HPV type distribution, costs and coverage with GLOBOCAN 2020 burden data.
It supports keeping the national HPV programme going after Gavi support.
Shares Ministère de la Santé, Burkina Faso, Cervical cancer.
Shares Ministère de la Santé, Burkina Faso, Cervical cancer.
Shares Ministère de la Santé, Burkina Faso, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/